Companies

Explore all the available companies. Are you wondering how to find wonderful businesses at great price? Start from A... or take a look at Compoundeer Ranking.

  1. Viper Networks Inc

    Viper Networks is a service provider of telecommunications, smart city and energy generation projects. Our 'Everything Wireless Telecom+Energy' strategy is designed to integrate mobility, fixed wireless, over-the-top ('OTT') technologies and smart cities into a single platform that can deployed in any market globally.

    VPER
  2. Vipshop Holdings Ltd

    Vipshop Holdings Limited is a leading online discount retailer for brands in China. Vipshop offers high quality and popular branded products to consumers throughout China at a significant discount to retail prices. Since it was founded in August 2008, the Company has rapidly built a sizeable and growing base of customers and brand partners.

    VIPS
  3. Viq Solutions Inc.

    VIQ Solutions is a global provider of secure, AI-driven, digital voice and video capture technology and transcription services. VIQ Solutions offers a seamless, comprehensive solution suite that delivers intelligent automation, enhanced with human review, to drive transformation in the way content is captured, secured, and repurposed into actionable information. The cyber-secure, AI technology and services platform are implemented in the most rigid security environments including criminal justice, legal, insurance, government, corporate finance, media, and transcription service provider markets, enabling them to improve the quality and accessibility of evidence, to easily identify predictive insights and to achieve digital transformation faster and at a lower cost.

    VQSSF
  4. Vir Biotechnology, Inc.

    Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a portfolio of preclinical programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology routinely posts information that may be important to investors on its website.

    VIR
  5. Viracta Therapeutics, Inc.

    Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants.

    VIRX
  6. Virax Biolabs Group Ltd

    Virax Biolabs Group Limited is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs Group Limited is developing T cell-based test technologies with the intention of providing an immunology profiling platform. T cell testing can be particularly effective in the diagnosis and therapeutics of post-acute infection syndromes such as Long COVID and other chronic conditions linked to immune dysregulation.

    VRAX
  7. Virbac Sa

    Virbac SA is a major drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America. Most of the company's sales are generated from its Companion Animals segment, followed by its Food Producing Animals segment. Veterinarians remain Virbac's main client, yet the company's clients are particularly diverse throughout the world in terms of profession, size and expectations. Virbac's strategy focuses on dominating niche markets while either avoiding or remaining differentiated within the more competitive markets.

    VRBCF
  8. Virco Mfg Corporation

    Virco Manufacturing Corp is engaged in designing, producing, and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells. Geographically, it operates in the United States and Canada.

    VIRC
  9. Vireo Growth Inc.

    Vireo was founded in 2014 as a pioneering medical cannabis company. Vireo is building a disciplined, strategically aligned, and execution-focused platform in the industry. This strategy drives our intense local market focus while leveraging the strength of a national portfolio. We are committed to hiring industry leaders and deploying capital and talent where we believe it will drive the most value. Vireo operates with a long-term mindset, a bias for action, and an unapologetic commitment to its customers, employees, shareholders, industry collaborators, and the communities it serves.

    VREOF
  10. Virgin Galactic Holdings, Inc

    Virgin Galactic is an aerospace and space travel company, pioneering human-first spaceflight for private individuals, researchers, and governments with its advanced SpaceShips and launch vehicle. Scale and profitability are driven by next-generation vehicles capable of bringing humans to space at an unprecedented frequency with an industry-leading cost structure.

    SPCE
  11. Virginia National Bankshares Corp

    Virginia National Bankshares Corporation, headquartered in Charlottesville, Virginia, is the bank holding company for Virginia National Bank. The Bank has seven banking offices throughout Fauquier and Prince William counties, four banking offices in Charlottesville and Albemarle County (including one limited-service banking facility), and banking offices in Winchester and Richmond, Virginia. The Bank offers a full range of banking and related financial services to meet the needs of individuals, businesses and charitable organizations, including the fiduciary services of VNB Trust and Estate Services. The Company's common stock trades on the Nasdaq Capital Market under the symbol "VABK." Additional information on the Company is also available at www.vnbcorp.com.

    VABK
  12. Viridian Therapeutics, Inc.\de

    Viridian is a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for patients with serious and rare diseases. Viridian's expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company conducted a pivotal program for veligrotug (VRDN-001), including two global phase 3 clinical trials (THRIVE and THRIVE-2), to evaluate its efficacy and safety in patients with active and chronic TED. Both THRIVE and THRIVE-2 reported positive topline data, meeting all the primary and secondary endpoints of each study.

    VRDN
  13. Virnetx Holding Corp

    VirnetX Holding Corporation is an Internet security software and technology company specializing in patented Zero Trust Network Access ('ZTNA') for secure network communications. The company's solutions, including its Secure Domain Name Registry and its flagship platform, VirnetX One, and products like War Room and VirnetX Matrix, are designed to be device and location independent and enable secure, real-time communication environments for U.S. defense, intelligence, and government agencies, as well as enterprise applications and critical infrastructure. The company also offers Digital Engineering services that align with defense strategies, including its comprehensive Cyber Threat Intelligence and assessment services and Model-Based System Engineering processes.

    VHC
  14. Virpax Pharmaceuticals, Inc.

    Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

    VRPX
  15. Virtra, Inc

    VirTra Inc is a US-based company which is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company includes installation, training, limited warranties, service agreements and related support. The company sells and supports use of force training and marksmanship firearms training systems and accessories for law enforcement, military or civilian use. The product line of the company includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat-Fire and other accessories.

    VTSI
  16. Virtu Financial, Inc.

    Virtu is a leading financial services firm that leverages cutting-edge technology to provide execution services and data, analytics and connectivity products to its clients and deliver liquidity to the global markets. Leveraging its global market making expertise and infrastructure, Virtu provides a robust product suite including offerings in execution, liquidity sourcing, analytics and broker-neutral, multi-dealer platforms in workflow technology. Virtu's product offerings allow clients to trade on hundreds of venues across 50+ countries and in multiple asset classes, including global equities, ETFs, foreign exchange, futures, fixed income and myriad other commodities. In addition, Virtu's integrated, multi-asset analytics platform provides a range of pre- and post-trade services, data products and compliance tools that clients rely upon to invest, trade and manage risk across global markets.

    VIRT
  17. Virtus Artificial Intelligence & Technology Opportunities Fund

    The Fund's investment objective attempts to simultaneously capture equity market exposure and current income utilizing a disciplined, fundamental, bottom-up research process combined with traditional credit analysis. The Fund attempts to reduce the risk of capital loss through, among other things, independent credit analysis focused on downgrade and default risks and the implementation of a clearly defined sell discipline strategy. The Fund will achieve its objective through a combination of current income, current gains and long-term capital appreciation. There is no guarantee that the Fund will achieve its investment objective. The use of leverage currently enables the Fund to borrow at short-term rates and invest at higher yields on its investments. As of July 31, 2022, the Funds leverage consisted of $130.0 million of borrowings made pursuant to margin financing and/or securities lending, which represented approximately 15% of the Funds total assets.

    AIO
  18. Virtus Convertible & Income Fund

    The Fund seeks total return through a combination of capital appreciation and high current income. The Fund will achieve its object through a combination of capital appreciation and high current income. There is no guarantee that the Fund will achieve its investment objective. The use of leverage currently enables the Fund to have a blended capital structure combining long-term fixed rates and short-term variable rates which allows the Fund to seek to enhance the yields on its investments. As of July 31, 2022, the Funds leverage consisted of $323.3 million of borrowings made pursuant to longer-term preferred shares, which represented approximately 45% of the Funds total assets.

    NCV
  19. Virtus Convertible & Income Fund Ii

    The Fund seeks total return through a combination of capital appreciation and high current income. The Fund will achieve its objective through a combination of capital appreciation and high current income. There is no guarantee that the Fund will achieve its investment objective. The use of leverage currently enables the Fund to have a blended capital structure combining long-term fixed rates and short-term variable rates which allows the Fund to seek to enhance the yields on its investments. As of July 31, 2022, the Funds leverage consisted of $271.5 million of borrowings made pursuant to longer-term preferred shares, which represented approximately 48% of the Funds total assets.

    NCZ
  20. Virtus Diversified Income & Convertible Fund

    Provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. The Fund will achieve its objective through a combination of current income and capital appreciation, while seeking to provide downside protection against capital loss. There is no guarantee that the Fund will achieve its investment objective. The Fund has a blended capital structure combining long-term fixed rates and short-term variable rates which enable the Fund to seek to enhance the returns and yields on its investments. As of July 31, 2022, the Funds leverage consisted of $105.0 million of borrowings made pursuant to long-term senior notes, short-term margin loan financing, and mandatory redeemable preferred shares, which represented approximately 30% of the Funds total assets.

    ACV
  21. Virtus Dividend, Interest & Premium Strategy Fund

    to seek current income and gains with a secondary objective of longterm capital appreciation Under normal circumstances, the Fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in securities and other instruments that provide dividends, interest or option premiums. The Fund will employ an option strategy of writing (selling) covered call options on equity securities held in the Fund.

    NFJ
  22. Virtus Equity & Convertible Income Fund

    Provide total return through a combination of current income and capital appreciation. Under normal circumstances, the Fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in a combination of equity securities and incomeproducing convertible securities. The equity component of the Fund may vary from 40-80% and the convertible component may vary from 20-60% of assets.

    NIE
  23. Virtus Global Multi-sector Income Fund

    Virtus Global Multi-Sector Inc is a diversified, closed-end management investment company.

    VGI
  24. Virtus Investment Partners, Inc.

    Virtus Investment Partners (NYSE: VRTS) is a distinctive partnership of boutique investment managers singularly committed to the long-term success of individual and institutional investors. We provide investment products and services from our investment managers , each with a distinct investment style and autonomous investment process, as well as select subadvisers. Investment solutions are available across multiple disciplines and product types to meet a wide array of investor needs.

    VRTS
  25. Virtus Stone Harbor Emerging Markets Income Fund

    The Fund seeks to maximize total return which consists of income on its investments and capital appreciaton.

    EDF
  26. Virtus Total Return Fund Inc.

    The Fund seeks total return, consisting of capital appreciation and income. The Fund seeks to meet its objectives through a balance of equity and fixed income investments. There is no guarantee that the Fund will achieve its investment objectives.

    ZTR
  27. Visa Inc.

    Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, sellers, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement.

    V
  28. Vishay Intertechnology Inc

    Vishay manufactures one of the world's largest portfolios of discrete semiconductors and passive electronic components that are essential to innovative designs in the automotive, industrial, computing, consumer, telecommunications, military, aerospace, and medical markets. Serving customers worldwide, Vishay is The DNA of tech.® Vishay Intertechnology, Inc. is a Fortune 1,000 Company listed on the NYSE (VSH). More on Vishay at www.vishay.com.

    VSH
  29. Vishay Precision Group, Inc.

    Vishay Precision Group, Inc. (VPG) is a leader in precision measurement and sensing technologies. Our sensors, weighing solutions and measurement systems optimize and enhance our customers' product performance across a broad array of markets to make our world safer, smarter, and more productive. To learn more, visit VPG at www.vpgsensors.com and follow us on LinkedIn.

    VPG
  30. Vision Marine Technologies Inc.

    Vision Marine Technologies (NASDAQ: VMAR) is a marine technology and retail group delivering premium boating experiences across internal combustion and electric segments. Through its E-Motion high-voltage propulsion platform and its Nautical Ventures retail network, Vision Marine offers an integrated ecosystem spanning propulsion, retail, service, and on-water consumer engagement.

    VMAR